MSB 2.67% $1.10 mesoblast limited

Ann: Submits New Information to FDA IND File for SR-aGVHD, page-294

  1. 208 Posts.
    lightbulb Created with Sketch. 101
    Potency assays and CMC approvals important for other studies to be approved to commence - A thought occurred to me about the importance of the potency assays and the CMC approvals and that is that approval of the assays and CMC issues being resolved was a pre-requisite for the commencement of other studies. From recollection ARDS and CLBP. Regardless of whether this constitutes a resubmission, acceptance of the assays and the CMC fixes is critically important to moving forward.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.10
Change
-0.030(2.67%)
Mkt cap ! $1.255B
Open High Low Value Volume
$1.12 $1.13 $1.09 $2.828M 2.568M

Buyers (Bids)

No. Vol. Price($)
20 53055 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.10 121233 13
View Market Depth
Last trade - 12.59pm 18/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.